• Citer

Intravenous Hemin, a potential heme oxygenase-1 activator, does not protect from post-ERCP acute pancreatitis in humans: Results of a randomized multicentric multinational placebo-controlled trial

par Yared, Rawad A.;Chen, Chieh Chang;Vandorpe, Astrid ;Arvanitakis, Marianna ;Delhaye, Myriam ;Viesca, Michael Fernandez Y.;Huberty, Vincent ;Blero, Daniel ;Toussaint, Emmanuel;Hittelet, Axel-Benoit ;Verset, Didier;Margos, Walter;Le Moine, Olivier ;Njimi, Hassane ;Liao, Wei Chih;Devière, Jacques ;Lemmers, Arnaud
Référence Pancreatology, 24, 3, page (363-369)
Publication Publié, 2024-05-01

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Intravenous Hemin, a potential heme oxygenase-1 activator, does not protect from post-ERCP acute pancreatitis in humans: Results of a randomized multicentric multinational placebo-controlled trial
Auteur:	Yared, Rawad A.; Chen, Chieh Chang; Vandorpe, Astrid; Arvanitakis, Marianna; Delhaye, Myriam; Viesca, Michael Fernandez Y.; Huberty, Vincent; Blero, Daniel; Toussaint, Emmanuel; Hittelet, Axel-Benoit; Verset, Didier; Margos, Walter; Le Moine, Olivier; Njimi, Hassane; Liao, Wei Chih; Devière, Jacques; Lemmers, Arnaud
Informations sur la publication:	Pancreatology, 24, 3, page (363-369)
Statut de publication:	Publié, 2024-05-01
Sujet CREF:	Gastro-entérologie
MeSH keywords:	Animals
	Humans
	Mice
	Anti-Inflammatory Agents, Non-Steroidal -- therapeutic use
	Cholangiopancreatography, Endoscopic Retrograde -- adverse effects
	Heme Oxygenase-1
	Hemin -- therapeutic use
	Lipase
	Pancreatitis -- etiology -- prevention & control
	Administration, Intravenous
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:1424-3903
	info:doi/10.1016/j.pan.2024.02.009
	info:pii/S142439032400036X
	info:scp/85186386074
	info:pmid/38431445